YARROW BIOSCIENCE, INC. Other Nonoperating Income (Expense)
YARROW BIOSCIENCE, INC. (YARW) reported Other Nonoperating Income (Expense) of $203.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $203.00K, a 88.69% decline year-over-year.
- YARROW BIOSCIENCE, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was $231.00K, a 61.11% decline year-over-year.
- YARROW BIOSCIENCE, INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was $1.79M, a 79.32% increase year-over-year.
- YARROW BIOSCIENCE, INC. other nonoperating income (expense) for the quarter ending 2025-03-31 was $594.00K, a 47.85% decline year-over-year.
- YARROW BIOSCIENCE, INC. other nonoperating income (expense) for fiscal 2023 was $1.39M, a 281.82% increase from fiscal 2022.
- YARROW BIOSCIENCE, INC. other nonoperating income (expense) for fiscal 2022 was $363.00K.
- YARROW BIOSCIENCE, INC. other nonoperating income (expense) for fiscal 2021 was -$135.00K, a 112.16% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. other nonoperating income (expense) for fiscal 2020 was $1.11M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $203.00K 10-Q · filed 2026-08-13 | $434.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $231.00K S-4/A · filed 2026-06-03 | ||||
| 2025-12-31 | $3.02M S-4/A · filed 2026-06-03 | ||||
| 2025-06-30 | $1.79M 10-Q · filed 2026-08-13 | $2.39M 10-Q · filed 2026-08-13 | $3.15M derived: sum of 3 quarters · filed 2026-08-13 | $4.08M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $594.00K S-4/A · filed 2026-06-03 | $1.35M derived: sum of 2 quarters · filed 2026-06-03 | $2.29M derived: sum of 3 quarters · filed 2026-06-03 | $3.29M derived: sum of 4 quarters · filed 2026-06-03 | |
| 2024-12-31 | $760.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | $1.69M derived: sum of 2 quarters · filed 2026-06-03 | $2.69M derived: sum of 3 quarters · filed 2026-06-03 | $3.83M S-4/A · filed 2026-06-03 | |
| 2024-09-30 | $934.00K 10-Q · filed 2024-11-07 | $1.94M derived: sum of 2 quarters · filed 2025-08-14 | $3.07M 10-Q · filed 2024-11-07 | $3.75M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-06-30 | $1.00M 10-Q · filed 2025-08-14 | $2.14M 10-Q · filed 2025-08-14 | $2.82M derived: sum of 3 quarters · filed 2025-08-14 | $2.98M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $1.14M 10-Q · filed 2025-05-08 | $1.82M derived: sum of 2 quarters · filed 2025-05-08 | $1.98M derived: sum of 3 quarters · filed 2025-05-08 | $2.26M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $680.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $843.00K derived: sum of 2 quarters · filed 2025-03-06 | $1.12M derived: sum of 3 quarters · filed 2025-03-06 | $1.39M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $163.00K 10-Q · filed 2024-11-07 | $443.00K derived: sum of 2 quarters · filed 2024-11-07 | $706.00K 10-Q · filed 2024-11-07 | $942.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $280.00K 10-Q · filed 2024-08-14 | $543.00K 10-Q · filed 2024-08-14 | $779.00K derived: sum of 3 quarters · filed 2024-08-14 | $857.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $263.00K 10-Q · filed 2024-05-09 | $499.00K derived: sum of 2 quarters · filed 2024-05-09 | $577.00K derived: sum of 3 quarters · filed 2024-05-09 | $629.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $314.00K derived: sum of 2 quarters · filed 2024-03-01 | $366.00K derived: sum of 3 quarters · filed 2024-03-01 | $363.00K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $78.00K 10-Q · filed 2023-11-13 | $130.00K derived: sum of 2 quarters · filed 2023-11-13 | $127.00K 10-Q · filed 2023-11-13 | $153.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $52.00K 10-Q · filed 2023-08-14 | $49.00K 10-Q · filed 2023-08-14 | $75.00K derived: sum of 3 quarters · filed 2023-08-14 | $40.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$3.00K 10-Q · filed 2023-05-11 | $23.00K derived: sum of 2 quarters · filed 2023-05-11 | -$12.00K derived: sum of 3 quarters · filed 2023-05-11 | -$81.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$9.00K derived: sum of 2 quarters · filed 2023-03-14 | -$78.00K derived: sum of 3 quarters · filed 2023-03-14 | -$135.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | -$35.00K 10-Q · filed 2022-11-14 | -$104.00K derived: sum of 2 quarters · filed 2022-11-14 | -$161.00K 10-Q · filed 2022-11-14 | -$192.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$69.00K 10-Q · filed 2022-08-12 | -$126.00K 10-Q · filed 2022-08-12 | -$157.00K derived: sum of 3 quarters · filed 2022-08-12 | -$287.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$57.00K 10-Q · filed 2022-05-12 | -$88.00K derived: sum of 2 quarters · filed 2022-05-12 | -$218.00K derived: sum of 3 quarters · filed 2022-05-12 | $330.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$161.00K derived: sum of 2 quarters · filed 2022-03-17 | $387.00K derived: sum of 3 quarters · filed 2022-03-17 | $1.11M 10-K · filed 2022-03-17 | -$1.11M 10-K · filed 2021-03-04 |
| 2020-09-30 | -$130.00K 10-Q · filed 2021-11-10 | $418.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.14M 10-Q · filed 2021-11-10 | -$2.41M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $548.00K 10-Q · filed 2021-08-12 | $1.27M 10-Q · filed 2021-08-12 | -$2.28M derived: sum of 3 quarters · filed 2021-08-12 | -$1.71M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $723.00K 10-Q · filed 2021-05-06 | -$2.82M derived: sum of 2 quarters · filed 2021-05-06 | -$2.25M derived: sum of 3 quarters · filed 2021-05-06 | -$1.51M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$2.98M derived: sum of 2 quarters · filed 2021-03-04 | -$2.24M derived: sum of 3 quarters · filed 2021-03-04 | -$1.44M 10-K · filed 2021-03-04 | $2.54M 10-K · filed 2020-03-03 |
| 2019-09-30 | $571.00K 10-Q · filed 2019-10-31 | $1.31M derived: sum of 2 quarters · filed 2019-10-31 | $2.11M 10-Q · filed 2019-10-31 | -$1.08M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-06-30 | $739.00K 10-Q · filed 2019-08-01 | $1.53M 10-Q · filed 2019-08-01 | -$1.65M derived: sum of 3 quarters · filed 2021-03-04 | -$794.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-03-31 | $796.00K 10-Q · filed 2019-05-02 | -$2.39M derived: sum of 2 quarters · filed 2021-03-04 | -$1.53M derived: sum of 3 quarters · filed 2021-03-04 | -$707.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2018-12-31 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$2.33M derived: sum of 2 quarters · filed 2021-03-04 | -$1.50M derived: sum of 3 quarters · filed 2021-03-04 | -$941.00K 10-K · filed 2021-03-04 | $3.09M 10-K · filed 2019-02-28 |
| 2018-09-30 | $855.00K 10-Q · filed 2019-10-31 | $1.68M derived: sum of 2 quarters · filed 2019-10-31 | $2.24M 10-Q · filed 2019-10-31 | $2.44M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-06-30 | $826.00K 10-Q · filed 2019-08-01 | $1.39M 10-Q · filed 2019-08-01 | $1.59M derived: sum of 3 quarters · filed 2020-03-03 | $1.75M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-03-31 | $563.00K 10-Q · filed 2019-05-02 | $764.00K derived: sum of 2 quarters · filed 2020-03-03 | $927.00K derived: sum of 3 quarters · filed 2020-03-03 | ||
| 2017-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $364.00K derived: sum of 2 quarters · filed 2020-03-03 | $517.00K 10-K · filed 2020-03-03 | ||
| 2017-09-30 | $163.00K 10-Q · filed 2018-11-07 | $316.00K 10-Q · filed 2018-11-07 | |||
| 2016-12-31 | $264.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |